...
search icon
spry-img

Silverback Therapeutics Inc, Common Stock

SPRY

NMQ

$13.49

-$0.53

(-3.78%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.37B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
178.25
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.47M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.94
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$7.55 L
$18.51 H
$13.49

About Silverback Therapeutics Inc, Common Stock

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameSPRYSectorS&P500
1-Week Return-3.44%-3.64%0.75%
1-Month Return5.14%0.66%10.79%
3-Month Return13.17%-7.56%-6.99%
6-Month Return-16.42%-9.22%-6.2%
1-Year Return42.45%-5.06%8.03%
3-Year Return358.84%7.07%40.36%
5-Year Return-46.04%36.87%94.27%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue17.84M5.51M1.32M30.00K89.15M[{"date":"2020-12-31","value":20.01,"profit":true},{"date":"2021-12-31","value":6.18,"profit":true},{"date":"2022-12-31","value":1.48,"profit":true},{"date":"2023-12-31","value":0.03,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue14.07M20.27M17.32M73.00K977.00K[{"date":"2020-12-31","value":69.4,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":85.43,"profit":true},{"date":"2023-12-31","value":0.36,"profit":true},{"date":"2024-12-31","value":4.82,"profit":true}]
Gross Profit3.77M(14.77M)(16.00M)(43.00K)88.17M[{"date":"2020-12-31","value":4.27,"profit":true},{"date":"2021-12-31","value":-16.75,"profit":false},{"date":"2022-12-31","value":-18.15,"profit":false},{"date":"2023-12-31","value":-0.05,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin21.11%(268.20%)(1216.11%)(143.33%)98.90%[{"date":"2020-12-31","value":21.34,"profit":true},{"date":"2021-12-31","value":-271.17,"profit":false},{"date":"2022-12-31","value":-1229.58,"profit":false},{"date":"2023-12-31","value":-144.92,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses18.30M24.96M36.83M67.55M91.25M[{"date":"2020-12-31","value":20.06,"profit":true},{"date":"2021-12-31","value":27.35,"profit":true},{"date":"2022-12-31","value":40.36,"profit":true},{"date":"2023-12-31","value":74.02,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(469.00K)(19.45M)(35.52M)(67.52M)(3.08M)[{"date":"2020-12-31","value":-46900000,"profit":false},{"date":"2021-12-31","value":-1945400000,"profit":false},{"date":"2022-12-31","value":-3551600000,"profit":false},{"date":"2023-12-31","value":-6752000000,"profit":false},{"date":"2024-12-31","value":-308300000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(1.06M)(20.24M)(34.68M)(54.37M)8.29M[{"date":"2020-12-31","value":-12.85,"profit":false},{"date":"2021-12-31","value":-244.3,"profit":false},{"date":"2022-12-31","value":-418.56,"profit":false},{"date":"2023-12-31","value":-656.11,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes(200.30K)(230.56K)(694.00K)(94.89K)288.00K[{"date":"2020-12-31","value":-69.55,"profit":false},{"date":"2021-12-31","value":-80.05,"profit":false},{"date":"2022-12-31","value":-240.97,"profit":false},{"date":"2023-12-31","value":-32.95,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(1.06M)(20.24M)(34.68M)(61.63M)8.00M[{"date":"2020-12-31","value":-13.32,"profit":false},{"date":"2021-12-31","value":-253.1,"profit":false},{"date":"2022-12-31","value":-433.63,"profit":false},{"date":"2023-12-31","value":-770.52,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(1.06M)(20.24M)(33.99M)(54.37M)8.00M[{"date":"2020-12-31","value":-13.32,"profit":false},{"date":"2021-12-31","value":-253.1,"profit":false},{"date":"2022-12-31","value":-424.96,"profit":false},{"date":"2023-12-31","value":-679.73,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)(2.07)(2.56)(0.98)(0.57)0.07[{"date":"2020-12-31","value":-2957.14,"profit":false},{"date":"2021-12-31","value":-3657.14,"profit":false},{"date":"2022-12-31","value":-1400,"profit":false},{"date":"2023-12-31","value":-814.29,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SPRY
Cash Ratio 13.40
Current Ratio 14.26
Quick Ratio 14.04

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SPRY
ROA (LTM) -0.66%
ROE (LTM) 3.28%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SPRY
Debt Ratio Lower is generally better. Negative is bad. 0.27
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.73

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SPRY
Trailing PE 178.25
Forward PE NM
P/S (TTM) 15.93
P/B 5.53
Price/FCF 34
EV/R 12.41
EV/Ebitda NM

FAQs

What is Silverback Therapeutics Inc share price today?

Silverback Therapeutics Inc (SPRY) share price today is $13.49

Can Indians buy Silverback Therapeutics Inc shares?

Yes, Indians can buy shares of Silverback Therapeutics Inc (SPRY) on Vested. To buy Silverback Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SPRY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Silverback Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Silverback Therapeutics Inc (SPRY) via the Vested app. You can start investing in Silverback Therapeutics Inc (SPRY) with a minimum investment of $1.

How to invest in Silverback Therapeutics Inc shares from India?

You can invest in shares of Silverback Therapeutics Inc (SPRY) via Vested in three simple steps:

  • Click on Sign Up or Invest in SPRY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Silverback Therapeutics Inc shares
What is Silverback Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Silverback Therapeutics Inc (SPRY) is $18.51. The 52-week low price of Silverback Therapeutics Inc (SPRY) is $7.55.

What is Silverback Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Silverback Therapeutics Inc (SPRY) is 178.25

What is Silverback Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Silverback Therapeutics Inc (SPRY) is 5.53

What is the Market Cap of Silverback Therapeutics Inc?

The market capitalization of Silverback Therapeutics Inc (SPRY) is $1.37B

What is Silverback Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Silverback Therapeutics Inc is SPRY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top